Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124819342 | 12481934 | 2 | F | 2014 | 20160725 | 20160620 | 20160803 | EXP | US-AMGEN-USASL2016076197 | AMGEN | 82.00 | YR | E | F | Y | 43.72000 | KG | 20160803 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124819342 | 12481934 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG, Q6MO | U | 125320 | 60 | MG | SOLUTION FOR INJECTION | ||||||
| 124819342 | 12481934 | 2 | C | AVASTIN | BEVACIZUMAB | 1 | UNK UNK, QMO | 0 | /month | ||||||||||
| 124819342 | 12481934 | 3 | C | EYLEA | AFLIBERCEPT | 1 | UNK UNK, QMO | 0 | /month | ||||||||||
| 124819342 | 12481934 | 4 | C | PRESERVISION | MINERALSVITAMINS | 1 | 0 | ||||||||||||
| 124819342 | 12481934 | 5 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 124819342 | 12481934 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 50000 UNIT, QMO | 0 | /month | ||||||||||
| 124819342 | 12481934 | 7 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 75 MUG, QD | 0 | 75 | UG | QD | |||||||
| 124819342 | 12481934 | 8 | C | MULTIVITAMIN | VITAMINS | 1 | UNK | 0 | |||||||||||
| 124819342 | 12481934 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 50000 UNIT, QMO | 0 | /month | |||||||||
| 124819342 | 12481934 | 10 | C | KEFLEX | CEPHALEXIN | 1 | 0 | ||||||||||||
| 124819342 | 12481934 | 11 | C | BIOTIN | BIOTIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124819342 | 12481934 | 1 | Osteoporosis postmenopausal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124819342 | 12481934 | OT |
| 124819342 | 12481934 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124819342 | 12481934 | Device physical property issue | |
| 124819342 | 12481934 | Fall | |
| 124819342 | 12481934 | Head injury | |
| 124819342 | 12481934 | Laceration | |
| 124819342 | 12481934 | Limb operation | |
| 124819342 | 12481934 | Osteomyelitis | |
| 124819342 | 12481934 | Osteonecrosis of jaw | |
| 124819342 | 12481934 | Periodontitis | |
| 124819342 | 12481934 | Syncope | |
| 124819342 | 12481934 | Tooth abscess | |
| 124819342 | 12481934 | Tooth fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124819342 | 12481934 | 1 | 201412 | 0 |